September 15, 2025

The Hidden Hazard: Fall-Risk Drugs

US fall-related deaths in older adults are rising, with prescription drugs a key contributor and safer alternatives urged.

KFF Health News

September 15, 2025

Chronic Insomnia Accelerates Cognitive Decline

Mayo Clinic study links chronic insomnia to 40% higher risk of cognitive impairment in older adults

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 10, 2025

What Role Do Omega-3s Play in Dementia Prevention?

Observational evidence suggests omega-3s may help shield aging brains, though randomized trials remain mixed.

Conexiant

September 08, 2025

Final Rest, First Do No Harm

On Cape Cod, a family chooses green burial, comparing costs, conservation cemeteries, human composting, and eco-friendly end-of-life options as demand grows.

KFF Health News

September 04, 2025

Persistent Grief Symptoms and Higher Mortality

Grief symptom trajectories serve as early indicators of future health care use, psychotropic medication needs, and mortality risk in bereaved individuals.

Conexiant

September 04, 2025

Less TV Time May Lower Depression Risk

Compositional data analysis reveals age-specific benefits of reallocating TV-watching time to other activities, including physical activity and sleep.

Conexiant

September 03, 2025

Vitiligo Depression Risk Varies by Race

Analysis of national health records shows vitiligo is linked to higher depression odds in certain racial and ethnic groups, highlighting variation in mental health burden across populations.

Conexiant

September 02, 2025

New Maintenance Option for Early Alzheimer’s Approved by FDA

FDA approves Leqembi IQLIK (lecanemab-irmb), a once-weekly subcutaneous autoinjector for maintenance treatment of early Alzheimer’s disease.

Conexiant